News

Filter

Current filters:

Cytarabine

1 to 9 of 73 results

Lintuzumab Ph IIb AMD trial completes enrollment

02-03-2009

US drug developer Seattle Genetics has completed patient enrollment in a Phase IIb trial of lintuzumab…

Cytarabine

Ph IIb lintuzumab trial passes interim review

22-12-2008

US drug developer Seattle Genetics says that a Phase IIb trial of lintuzumab (SGN-33) plus low-dose cytarabine…

Cytarabine

AS1413 achieves 42% remission rate in AML

15-12-2008

UK cancer drug developer Antisoma says that 42% of patients taking its late-stage candidate AS1413 responded…

CerubidineCytarabineDaunorubicin

Antisoma reports initial AML trial data

21-07-2008

Antisoma has reported initial findings from its Phase II trial of AS1411 in relapsed and refractory acute…

Cytarabine

Sunesis cuts 60% of staff; focus on voreloxin

16-06-2008

The USA's Sunesis Pharmaceuticals will lose 60% of its workforce and halt research activities, focusing…

Cytarabine

1 to 9 of 73 results

COMPANY SPOTLIGHT

Menarini

Back to top